2024 Marketing Ownership Registration 
Intellectual Property Law Blog
MARCH 13, 2024
The United States Patent and Trademark Office (“USPTO”) and the United States Copyright Office (“USCO”) delivered a report to Congress entitled Non-Fungible Tokens and Intellectual Property on March 12, 2024 (“Report”). While the Report is comprehensive, it does not recommend any new action to address IP issues with NFTs.
The TTABlog
FEBRUARY 7, 2024
The Board dismissed an opposition to registration of SPLIT DECISION for "Entertainment services in the nature of live visual and audio performances, namely, musical rock band," finding that Opposer Billy Stott failed to carry his burden to prove that Applicant Split Decision Music, LLC was not the owner of the mark. Billy Stott v.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
AUGUST 14, 2023
The reporting rule goes into effect on January 1, 2024. CTA defines a beneficial owner as an individual who, directly or indirectly, either (1) exercises substantial control over a Reporting Company or (2) owns or controls at least 25% of the ownership interests of a Reporting Company. What is Considered an Ownership Interest?
LexBlog IP
MARCH 13, 2024
The United States Patent and Trademark Office (“USPTO”) and the United States Copyright Office (“USCO”) delivered a report to Congress entitled Non-Fungible Tokens and Intellectual Property on March 12, 2024 (“Report”).
LexBlog IP
AUGUST 29, 2023
Any entity that qualifies as a domestic or foreign reporting company must file “beneficial ownership reports” with FinCEN, unless specifically excluded under one of the enumerated exemptions. The CTA specifically exempts 23 categories of companies that would otherwise be required to file beneficial ownership reports.
LexBlog IP
JANUARY 17, 2024
Any entity that qualifies as a domestic or foreign reporting company must file beneficial ownership reports ( “BOI” ) with FinCEN, unless specifically excluded under one of the enumerated exemptions. The CTA takes effect on January 1, 2024. Which entities must file BOI reports under the CTA?
SpicyIP
JANUARY 29, 2024
In a major development concerning the Ibrutinib patent, DHC restrains generic manufacturers from manufacturing and marketing the life-saving anti-cancer drug. Last date to Register: 29th February 2024 Case Summaries Premier Spg And Wvg Mills Pvt. But what about the public interest? Read Tejaswini’s post to know more.
Expert insights. Personalized for you.
130 
Let's personalize your content